Menu
Back to Journals » Cancer Management and Research » Volume 11
Original Research
Elevated levels of pre-treatment lactate dehydrogenase are an unfavorable predictor factor in patients with EML4-ALK rearrangement non-small cell lung cancer treated with crizotinib
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 6,620 | Dovepress* | 6,088+ | 716 | 6,804 | |
| PubMed Central* | 532 | 120 | 652 | ||
| Totals | 6,620 | 836 | 7,456 | ||
| *Since 5 September 2019 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 1 | 0 | 1 |
View citations on PubMed Central and Google Scholar